Hematopoietic Cell Transplantation Clinical Trial
Official title:
Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
This is a prospective, observational multicenter study to collect blood from patients with mucopolysaccharidosis type IH undergoing laronidase therapy and a stem cell transplant. Sixteen patients will be enrolled over a 24 month period.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03179761 -
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
|
Phase 2 | |
Recruiting |
NCT05090345 -
A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
|
||
Completed |
NCT05600101 -
Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT05866302 -
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
|
||
Completed |
NCT04139577 -
FMT In High-Risk Acute GVHD After ALLO HCT
|
Phase 1 | |
Completed |
NCT04727827 -
Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation
|
N/A |